Halaman 2 - Kemoterapi untuk kanker prostat Dokter Terbaik - TOP-38 dokter

Prof. Madya Nail Paksoy, seorang onkolog medis di Rumah Sakit Medipol Bahçelievler, berspesialisasi dalam kemoterapi untuk kanker prostat dengan pengalaman uji klinis yang luas.

• Bersertifikat Dewan ESMO dalam Onkologi Medis
• Kontributor dalam 8 uji klinis internasional mengenai perawatan kanker stadium lanjut
• Menerbitkan berbagai studi tentang protokol kemoterapi baru
• Berspesialisasi dalam pendekatan perawatan yang dipersonalisasi untuk kanker prostat

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Alemdar berspesialisasi dalam onkologi medis dengan fokus pada pengobatan kanker prostat di Kompleks Rumah Sakit Medical Park Antalya.

• Bersertifikat dewan dalam onkologi medis sejak 2018
• Pengalaman luas di berbagai rumah sakit bergengsi
• Pelatihan lanjutan dari Akdeniz University
• Berdedikasi pada protokol kemoterapi yang dipersonalisasi

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Profesor Madya Onkologi Medis di Universitas İstinye, Dr. Atci berspesialisasi dalam pengobatan kanker prostat stadium lanjut.

• Telah menerbitkan 19+ artikel yang ditinjau sejawat tentang luaran onkologi
• Anggota American Society of Clinical Oncology (ASCO)
• Koordinator Pendidikan untuk Subspesialisasi Onkologi Medis
• Bekerja di Liv Hospital Topkapı – pusat onkologi terkemuka

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Lebih dari 50.000 operasi kanker telah dilakukan – Dr. Raj Nagarkar membawa pengalaman luas dalam pengobatan kanker prostat di HCG Manavata Cancer Centre.

• Menempuh pendidikan di Tata Memorial Hospital dan Royal College of Surgeons
• Terlibat dalam 200+ uji klinis untuk pengobatan baru
• Fokus khusus pada Onkologi Bedah Payudara dan Toraks
• Profesor untuk Subspesialisasi DNB Onkologi Bedah

Dr. Shaunak Valame mempresentasikan penelitiannya tentang kanker lambung di Gastrointestinal Cancer Symposium yang bergengsi oleh ASCO.

• Menjalani pelatihan Onkologi Medis di Indraprastha Apollo Hospital
• Spesialisasi dalam dasar molekuler kanker dan terapi target
• Pengalaman sebagai Registrar di Onkologi Medis di Jawaharlal Nehru Cancer Hospital
• Memberikan kuliah di International Winter School of Oncology di AIIMS

Dr. Lalit Banswal melakukan operasi kanker invasif minimal dengan hasil yang sangat baik – di HCG Manavata Cancer Centre.

• Pengalaman onkologi bedah 10+ tahun
• Telah melakukan lebih dari 10.000 operasi besar
• Pelatihan kanker gastrointestinal di Tata Medical Centre
• Menerbitkan berbagai makalah penelitian nasional dan internasional
• Dikenal karena pendekatan etis dan ramah pasien

Dr. Shaikh berspesialisasi dalam bedah kanker mulut dan rehabilitasi fungsional di HCG Manavata Cancer Centre.

• 3 tahun pengalaman terfokus dalam onkologi bedah
• Pelatihan Fellowship dalam Onkologi Bedah Kepala & Leher
• Pakar dalam teknik preservasi organ
• Mahir dalam bedah maksilofasial mayor
• Peneliti yang telah dipublikasikan di bidang ini

Ahli dalam imunoterapi dan terapi metronomik untuk kanker stadium lanjut – Dr. Kate menempuh pendidikan di Tata Memorial Hospital, salah satu pusat kanker terkemuka di India.

• Spesialisasi dalam kanker paru-paru, payudara, dan genitourinari
• Anggota ASCO, ESMO, dan perkumpulan onkologi terkemuka lainnya
• Mempresentasikan penelitian kanker paru-paru di World Conference on Lung Cancer
• Penerima penghargaan perjalanan WCLC yang bergengsi pada tahun 2018

Dr. Chaitainya Borde telah menangani lebih dari 30.000 pemindaian PET dan 1.000 pasien kanker tiroid di HCG Manavata Cancer Centre.

• 12 tahun pengalaman dalam kedokteran nuklir
• Spesialisasi dalam terapi radioiodin dan Lu-177 RN
• Mahir dalam semua jenis pemindaian nuklir dan pemindaian PET-CT
• Makalah yang diterbitkan di berbagai jurnal medis

Dr. Sridhar P.S. berspesialisasi dalam radioterapi dan kemoterapi untuk kanker prostat di HCG Manavata Cancer Centre.

• Pengalaman lebih dari 20 tahun di bidang onkologi radiasi
• Diplomate of National Board dalam radioterapi
• Anggota Association of Radiation Oncology of India
• Aktif dalam Society for Neuro-Oncology